WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996004368) PROPAGATION AND INDUCIBLE DIFFERENTIATION OF HUMAN FETAL CENTRAL NERVOUS SYSTEM PROGENITOR CELLS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/004368    International Application No.:    PCT/CA1995/000445
Publication Date: 15.02.1996 International Filing Date: 31.07.1995
Chapter 2 Demand Filed:    29.02.1996    
IPC:
C12N 5/0797 (2010.01)
Applicants: DALHOUSIE UNIVERSITY [CA/CA]; Technology Transfer Office, Arts & Administration Building, 6299 South Street, Halifax, Nova Scotia B3H 4H6 (CA)
Inventors: FINE, Alan; (US).
CHALMERS-REDMAN, Ruth, M., E.; (CA)
Agent: GRAVELLE, Micheline; Smart & Biggar, Suite 2300, 439 University Avenue, Toronto, Ontario M5G 1Y8 (CA)
Priority Data:
282,927 29.07.1994 US
Title (EN) PROPAGATION AND INDUCIBLE DIFFERENTIATION OF HUMAN FETAL CENTRAL NERVOUS SYSTEM PROGENITOR CELLS
(FR) PROPAGATION ET DIFFERENCIATION INDUCTIBLE DE CELLULES SOUCHES DU SYSTEME NERVEUX CENTRAL F×TAL HUMAIN
Abstract: front page image
(EN)The present invention provides a process of preparing proliferating human fetal central nervous system progenitor or differentiated cells and cells prepared by that process. Proliferating progenitor cells are prepared by culturing human fetal, central nervous system tissue in a non-adherent culture container containing medium comprising serum and epidermal growth factor. A screening assay and $i(ex vivo) treatments using those cells are also provided.
(FR)L'invention concerne un procédé de préparation de cellules souches ou différenciées du système nerveux central f÷tal humain prolifératives ainsi que des cellules préparées selon ce procédé. Les cellules souches prolifératives sont préparées par mise en culture de tissu du système nerveux central de f÷tus humain dans un conteneur de culture non adhérent contenant du sérum et un facteur de croissance épidermique. L'invention concerne également une méthode de criblage ainsi que des traitements $i(ex vivo) utilisant ces cellules.
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)